{"schema_version":"1","generated_at":"2026-10-28T07:12:56.542Z","data_as_of":null,"url":"https://www.findmykol.com/kol/christine-parseghian","json_url":"https://www.findmykol.com/kol/christine-parseghian/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"christine-parseghian","name":"Christine Parseghian","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"The University of Texas MD Anderson Cancer Center","institution_url":"https://www.findmykol.com/institution/the-university-of-texas-md-anderson-cancer-center","city":"Houston","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1922373265","orcid":"0000-0002-2047-097X","openalex":"A5009371984"},"summary":"Christine Parseghian is an Oncology physician affiliated with The University of Texas MD Anderson Cancer Center. OpenAlex indexes 233 publications with 1,767 citations (h-index 22); ClinicalTrials.gov lists 5 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":233,"cited_by_count":1767,"h_index":22,"latest_activity_year":2025,"source":"works"},"trials":{"count":5,"shown":3,"withheld":2,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06412198","title":"A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations","phase":"PHASE1/PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"M.D. Anderson Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT06412198","trial_url":"https://www.findmykol.com/trial/NCT06412198"},{"nct":"NCT06369259","title":"Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"M.D. Anderson Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT06369259","trial_url":"https://www.findmykol.com/trial/NCT06369259"},{"nct":"NCT05985954","title":"Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy","phase":"PHASE1","status":"RECRUITING","role":"Overall official","sponsor":"M.D. Anderson Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT05985954","trial_url":"https://www.findmykol.com/trial/NCT05985954"}],"source":"trials"},"payments":{"company_count":7,"program_years":{"first":2021,"last":null},"rows_total":9,"shown":3,"withheld":6,"rows":[{"payer":"Amgen Inc.","program_year":2025,"amount_usd":4230.49,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1922373265"},{"payer":"Janssen Scientific Affairs, LLC","program_year":2025,"amount_usd":2560,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1922373265"},{"payer":"Merck KGaA","program_year":2024,"amount_usd":3967.5,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1922373265"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1922373265","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitors","year":2025,"journal":"Annals of Oncology","source_url":"https://doi.org/10.1016/j.annonc.2025.01.020","status":"verified"},{"title":"Mutational and co-mutational landscape of early onset colorectal cancer","year":2025,"journal":"Biomarkers","source_url":"https://doi.org/10.1080/1354750x.2024.2447089","status":"verified"},{"title":"Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAFV600E metastatic colorectal cancer","year":2025,"journal":"Cancer Cell","source_url":"https://doi.org/10.1016/j.ccell.2025.08.002","status":"verified"},{"title":"Adaptive Plasticity Tumor Cells Modulate MAPK-Targeting Therapy Response in Colorectal Cancer","year":2025,"journal":"bioRxiv (Cold Spring Harbor Laboratory)","source_url":"https://doi.org/10.1101/2025.01.22.634215","status":"verified"},{"title":"732MO Circulating tumour DNA (ctDNA) clearance and correlation with outcome in the INTERCEPT colorectal cancer (CRC) study","year":2025,"journal":"Annals of Oncology","source_url":"https://doi.org/10.1016/j.annonc.2025.08.1307","status":"verified"}],"source":"works"},"contact":{"address_1":"1515 HOLCOMBE BLVD","city":"Houston","state":"TX","zip":"770304000","phone":"713-792-6161","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1922373265","source":"identity"},"similar":[{"name":"Hagop Kantarjian","slug":"hagop-kantarjian","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/hagop-kantarjian","json_url":"https://www.findmykol.com/kol/hagop-kantarjian/profile.json"},{"name":"Gabriel Hortobagyi","slug":"gabriel-hortobagyi","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/gabriel-hortobagyi","json_url":"https://www.findmykol.com/kol/gabriel-hortobagyi/profile.json"},{"name":"Jaffer Ajani","slug":"jaffer-ajani","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jaffer-ajani","json_url":"https://www.findmykol.com/kol/jaffer-ajani/profile.json"},{"name":"Funda Meric-Bernstam","slug":"funda-meric-bernstam","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Surgery","url":"https://www.findmykol.com/kol/funda-meric-bernstam","json_url":"https://www.findmykol.com/kol/funda-meric-bernstam/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":2,"payments":6,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2023-05-24","provider_certified":"2023-05-24","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}